id	sid	tid	token	lemma	pos
egc-304	1	1	eglobal	eglobal	PROPN
egc-304	1	2	congress	congress	PROPN
egc-304	1	3	hosted	host	VERB
egc-304	1	4	online	online	ADV
egc-304	1	5	from	from	ADP
egc-304	1	6	dubai	dubai	PROPN
egc-304	1	7	,	,	PUNCT
egc-304	1	8	u.	u.	PROPN
egc-304	1	9	a.	a.	PROPN
egc-304	1	10	e.	e.	PROPN
egc-304	1	11	,	,	PUNCT
egc-304	1	12	e	e	PROPN
egc-304	1	13	conference	conference	NOUN
egc-304	1	14	.	.	PUNCT
egc-304	2	1	date	date	NOUN
egc-304	2	2	:	:	PUNCT
egc-304	2	3	30th	30th	ADJ
egc-304	2	4	january	january	PROPN
egc-304	2	5	2025	2025	NUM
egc-304	2	6	website	website	NOUN
egc-304	2	7	:	:	PUNCT
egc-304	2	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	2	9	issn	issn	PROPN
egc-304	2	10	(	(	PUNCT
egc-304	2	11	e	e	NOUN
egc-304	2	12	):	):	PUNCT
egc-304	2	13	2836	2836	NUM
egc-304	2	14	-	-	SYM
egc-304	2	15	3612	3612	NUM
egc-304	2	16	44	44	NUM
egc-304	2	17	|	|	ADV
egc-304	2	18	p	p	NOUN
egc-304	2	19	a	a	DET
egc-304	2	20	g	g	NOUN
egc-304	2	21	e	e	NOUN
egc-304	2	22	metabolic	metabolic	NOUN
egc-304	2	23	syndrome	syndrome	NOUN
egc-304	2	24	in	in	ADP
egc-304	2	25	women	woman	NOUN
egc-304	2	26	with	with	ADP
egc-304	2	27	vitamin	vitamin	NOUN
egc-304	2	28	d	d	NOUN
egc-304	2	29	deficiency	deficiency	NOUN
egc-304	2	30	:	:	PUNCT
egc-304	2	31	issues	issue	NOUN
egc-304	2	32	of	of	ADP
egc-304	2	33	pathogenesis	pathogenesis	NOUN
egc-304	2	34	and	and	CCONJ
egc-304	2	35	diagnostics	diagnostic	NOUN
egc-304	2	36	khasanova	khasanova	PROPN
egc-304	2	37	gulchehra	gulchehra	PROPN
egc-304	2	38	khikmatovna	khikmatovna	PROPN
egc-304	2	39	senior	senior	ADJ
egc-304	2	40	lecturer	lecturer	NOUN
egc-304	2	41	,	,	PUNCT
egc-304	2	42	department	department	NOUN
egc-304	2	43	of	of	ADP
egc-304	2	44	applied	apply	VERB
egc-304	2	45	cosmetology	cosmetology	NOUN
egc-304	2	46	,	,	PUNCT
egc-304	2	47	kimyo	kimyo	NOUN
egc-304	2	48	international	international	ADJ
egc-304	2	49	university	university	PROPN
egc-304	2	50	in	in	ADP
egc-304	2	51	tashkent	tashkent	PROPN
egc-304	2	52	,	,	PUNCT
egc-304	2	53	tashkent	tashkent	PROPN
egc-304	2	54	,	,	PUNCT
egc-304	2	55	uzbekistan	uzbekistan	PROPN
egc-304	2	56	,	,	PUNCT
egc-304	2	57	gulchehra.kh@ya.ru	gulchehra.kh@ya.ru	PROPN
egc-304	2	58	tukhtaeva	tukhtaeva	PROPN
egc-304	2	59	nigora	nigora	PROPN
egc-304	2	60	khasanovna	khasanovna	PROPN
egc-304	2	61	md	md	PROPN
egc-304	2	62	,	,	PUNCT
egc-304	2	63	associate	associate	NOUN
egc-304	2	64	professor	professor	NOUN
egc-304	2	65	,	,	PUNCT
egc-304	2	66	department	department	NOUN
egc-304	2	67	of	of	ADP
egc-304	2	68	propaedeutics	propaedeutic	NOUN
egc-304	2	69	of	of	ADP
egc-304	2	70	internal	internal	ADJ
egc-304	2	71	medicine	medicine	NOUN
egc-304	2	72	no	no	NOUN
egc-304	2	73	.	.	PROPN
egc-304	2	74	2	2	NUM
egc-304	2	75	,	,	PUNCT
egc-304	2	76	tashkent	tashkent	PROPN
egc-304	2	77	medical	medical	PROPN
egc-304	2	78	academy	academy	PROPN
egc-304	2	79	,	,	PUNCT
egc-304	2	80	tashkent	tashkent	PROPN
egc-304	2	81	,	,	PUNCT
egc-304	2	82	uzbekistan	uzbekistan	NOUN
egc-304	2	83	relevance	relevance	NOUN
egc-304	2	84	according	accord	VERB
egc-304	2	85	to	to	ADP
egc-304	2	86	the	the	PRON
egc-304	2	87	who	who	PRON
egc-304	2	88	,	,	PUNCT
egc-304	2	89	1.7	1.7	NUM
egc-304	2	90	billion	billion	NUM
egc-304	2	91	people	people	NOUN
egc-304	2	92	on	on	ADP
egc-304	2	93	the	the	DET
egc-304	2	94	planet	planet	NOUN
egc-304	2	95	are	be	AUX
egc-304	2	96	overweight	overweight	ADJ
egc-304	2	97	,	,	PUNCT
egc-304	2	98	and	and	CCONJ
egc-304	2	99	by	by	ADP
egc-304	2	100	2025	2025	NUM
egc-304	2	101	,	,	PUNCT
egc-304	2	102	the	the	DET
egc-304	2	103	number	number	NOUN
egc-304	2	104	of	of	ADP
egc-304	2	105	obese	obese	ADJ
egc-304	2	106	people	people	NOUN
egc-304	2	107	in	in	ADP
egc-304	2	108	the	the	DET
egc-304	2	109	world	world	NOUN
egc-304	2	110	will	will	AUX
egc-304	2	111	reach	reach	VERB
egc-304	2	112	300	300	NUM
egc-304	2	113	million	million	NUM
egc-304	2	114	people	people	NOUN
egc-304	3	1	[	[	X
egc-304	3	2	1	1	NUM
egc-304	3	3	]	]	PUNCT
egc-304	3	4	.	.	PUNCT
egc-304	4	1	according	accord	VERB
egc-304	4	2	to	to	ADP
egc-304	4	3	the	the	DET
egc-304	4	4	definition	definition	NOUN
egc-304	4	5	of	of	ADP
egc-304	4	6	the	the	DET
egc-304	4	7	world	world	PROPN
egc-304	4	8	health	health	PROPN
egc-304	4	9	organization	organization	NOUN
egc-304	4	10	,	,	PUNCT
egc-304	4	11	obesity	obesity	NOUN
egc-304	4	12	is	be	AUX
egc-304	4	13	defined	define	VERB
egc-304	4	14	as	as	ADP
egc-304	4	15	an	an	DET
egc-304	4	16	unusual	unusual	ADJ
egc-304	4	17	or	or	CCONJ
egc-304	4	18	excessive	excessive	ADJ
egc-304	4	19	accumulation	accumulation	NOUN
egc-304	4	20	of	of	ADP
egc-304	4	21	fat	fat	NOUN
egc-304	4	22	that	that	PRON
egc-304	4	23	can	can	AUX
egc-304	4	24	be	be	AUX
egc-304	4	25	harmful	harmful	ADJ
egc-304	4	26	to	to	ADP
egc-304	4	27	health	health	NOUN
egc-304	4	28	.	.	PUNCT
egc-304	5	1	it	it	PRON
egc-304	5	2	is	be	AUX
egc-304	5	3	a	a	DET
egc-304	5	4	global	global	ADJ
egc-304	5	5	medical	medical	ADJ
egc-304	5	6	and	and	CCONJ
egc-304	5	7	social	social	ADJ
egc-304	5	8	problem	problem	NOUN
egc-304	5	9	for	for	ADP
egc-304	5	10	the	the	DET
egc-304	5	11	health	health	NOUN
egc-304	5	12	of	of	ADP
egc-304	5	13	all	all	DET
egc-304	5	14	countries	country	NOUN
egc-304	5	15	and	and	CCONJ
egc-304	5	16	patients	patient	NOUN
egc-304	5	17	of	of	ADP
egc-304	5	18	all	all	DET
egc-304	5	19	ages	age	NOUN
egc-304	5	20	.	.	PUNCT
egc-304	6	1	the	the	DET
egc-304	6	2	incidence	incidence	NOUN
egc-304	6	3	of	of	ADP
egc-304	6	4	metabolic	metabolic	NOUN
egc-304	6	5	syndrome	syndrome	NOUN
egc-304	6	6	(	(	PUNCT
egc-304	6	7	ms	ms	NOUN
egc-304	6	8	)	)	PUNCT
egc-304	6	9	in	in	ADP
egc-304	6	10	the	the	DET
egc-304	6	11	world	world	NOUN
egc-304	6	12	is	be	AUX
egc-304	6	13	almost	almost	ADV
egc-304	6	14	40	40	NUM
egc-304	6	15	%	%	NOUN
egc-304	6	16	of	of	ADP
egc-304	6	17	the	the	DET
egc-304	6	18	adult	adult	NOUN
egc-304	6	19	population	population	NOUN
egc-304	6	20	,	,	PUNCT
egc-304	6	21	and	and	CCONJ
egc-304	6	22	obesity	obesity	NOUN
egc-304	6	23	is	be	AUX
egc-304	6	24	13	13	NUM
egc-304	6	25	%	%	NOUN
egc-304	6	26	(	(	PUNCT
egc-304	6	27	lee	lee	PROPN
egc-304	6	28	et	et	PROPN
egc-304	6	29	al	al	PROPN
egc-304	6	30	.	.	PROPN
egc-304	6	31	,	,	PUNCT
egc-304	6	32	2020	2020	NUM
egc-304	6	33	)	)	PUNCT
egc-304	6	34	.	.	PUNCT
egc-304	7	1	the	the	DET
egc-304	7	2	global	global	ADJ
egc-304	7	3	prevalence	prevalence	NOUN
egc-304	7	4	of	of	ADP
egc-304	7	5	obesity	obesity	NOUN
egc-304	7	6	has	have	AUX
egc-304	7	7	almost	almost	ADV
egc-304	7	8	tripled	triple	VERB
egc-304	7	9	from	from	ADP
egc-304	7	10	1975	1975	NUM
egc-304	7	11	to	to	ADP
egc-304	7	12	2016	2016	NUM
egc-304	7	13	and	and	CCONJ
egc-304	7	14	continues	continue	VERB
egc-304	7	15	to	to	PART
egc-304	7	16	increase	increase	VERB
egc-304	7	17	.	.	PUNCT
egc-304	8	1	in	in	ADP
egc-304	8	2	the	the	DET
egc-304	8	3	united	united	PROPN
egc-304	8	4	states	states	PROPN
egc-304	8	5	42.4	42.4	NUM
egc-304	8	6	%	%	NOUN
egc-304	8	7	in	in	ADP
egc-304	8	8	2018	2018	NUM
egc-304	8	9	,	,	PUNCT
egc-304	8	10	in	in	ADP
egc-304	8	11	france	france	PROPN
egc-304	8	12	,	,	PUNCT
egc-304	8	13	the	the	DET
egc-304	8	14	prevalence	prevalence	NOUN
egc-304	8	15	of	of	ADP
egc-304	8	16	obesity	obesity	NOUN
egc-304	8	17	among	among	ADP
egc-304	8	18	adults	adult	NOUN
egc-304	8	19	was	be	AUX
egc-304	8	20	17	17	NUM
egc-304	8	21	%	%	NOUN
egc-304	8	22	in	in	ADP
egc-304	8	23	the	the	DET
egc-304	8	24	same	same	ADJ
egc-304	8	25	year	year	NOUN
egc-304	8	26	.	.	PUNCT
egc-304	9	1	recent	recent	ADJ
egc-304	9	2	studies	study	NOUN
egc-304	9	3	have	have	AUX
egc-304	9	4	shown	show	VERB
egc-304	9	5	that	that	SCONJ
egc-304	9	6	both	both	PRON
egc-304	9	7	vitamin	vitamin	NOUN
egc-304	9	8	d	d	NOUN
egc-304	9	9	deficiency	deficiency	NOUN
egc-304	9	10	and	and	CCONJ
egc-304	9	11	carriage	carriage	NOUN
egc-304	9	12	of	of	ADP
egc-304	9	13	certain	certain	ADJ
egc-304	9	14	polymorphisms	polymorphism	NOUN
egc-304	9	15	of	of	ADP
egc-304	9	16	the	the	DET
egc-304	9	17	vitamin	vitamin	NOUN
egc-304	9	18	d	d	NOUN
egc-304	9	19	receptor	receptor	NOUN
egc-304	9	20	gene	gene	NOUN
egc-304	9	21	may	may	AUX
egc-304	9	22	be	be	AUX
egc-304	9	23	associated	associate	VERB
egc-304	9	24	with	with	ADP
egc-304	9	25	an	an	DET
egc-304	9	26	increase	increase	NOUN
egc-304	9	27	in	in	ADP
egc-304	9	28	the	the	DET
egc-304	9	29	fractions	fraction	NOUN
egc-304	9	30	of	of	ADP
egc-304	9	31	atherogenic	atherogenic	ADJ
egc-304	9	32	blood	blood	NOUN
egc-304	9	33	lipids	lipids	ADP
egc-304	9	34	[	[	X
egc-304	9	35	2	2	NUM
egc-304	9	36	]	]	PUNCT
egc-304	9	37	.	.	PUNCT
egc-304	10	1	to	to	ADP
egc-304	10	2	date	date	NOUN
egc-304	10	3	,	,	PUNCT
egc-304	10	4	the	the	DET
egc-304	10	5	relationship	relationship	NOUN
egc-304	10	6	between	between	ADP
egc-304	10	7	the	the	DET
egc-304	10	8	concentration	concentration	NOUN
egc-304	10	9	of	of	ADP
egc-304	10	10	25	25	NUM
egc-304	10	11	hydroxyvitamin	hydroxyvitamin	NOUN
egc-304	10	12	d	d	NOUN
egc-304	10	13	(	(	PUNCT
egc-304	10	14	25(oh)d	25(oh)d	NOUN
egc-304	10	15	)	)	PUNCT
egc-304	10	16	in	in	ADP
egc-304	10	17	the	the	DET
egc-304	10	18	blood	blood	NOUN
egc-304	10	19	serum	serum	NOUN
egc-304	10	20	and	and	CCONJ
egc-304	10	21	ms	ms	NOUN
egc-304	10	22	is	be	AUX
egc-304	10	23	being	be	AUX
egc-304	10	24	actively	actively	ADV
egc-304	10	25	studied	study	VERB
egc-304	10	26	(	(	PUNCT
egc-304	10	27	maroufi	maroufi	PROPN
egc-304	10	28	n.f	n.f	PROPN
egc-304	10	29	.	.	PROPN
egc-304	10	30	et	et	PROPN
egc-304	10	31	al	al	PROPN
egc-304	10	32	.	.	PROPN
egc-304	10	33	,	,	PUNCT
egc-304	10	34	2020	2020	NUM
egc-304	10	35	;	;	PUNCT
egc-304	10	36	weldegiorgis	weldegiorgis	PROPN
egc-304	10	37	t.z	t.z	PROPN
egc-304	10	38	.	.	PROPN
egc-304	10	39	et	et	PROPN
egc-304	10	40	al	al	PROPN
egc-304	10	41	.	.	PROPN
egc-304	10	42	,	,	PUNCT
egc-304	10	43	2022	2022	NUM
egc-304	10	44	)	)	PUNCT
egc-304	10	45	.	.	PUNCT
egc-304	11	1	thus	thus	ADV
egc-304	11	2	,	,	PUNCT
egc-304	11	3	the	the	DET
egc-304	11	4	results	result	NOUN
egc-304	11	5	of	of	ADP
egc-304	11	6	the	the	DET
egc-304	11	7	20year	20year	NUM
egc-304	11	8	prospective	prospective	ADJ
egc-304	11	9	cardia	cardia	NOUN
egc-304	11	10	study	study	NOUN
egc-304	11	11	,	,	PUNCT
egc-304	11	12	which	which	PRON
egc-304	11	13	initially	initially	ADV
egc-304	11	14	included	include	VERB
egc-304	11	15	young	young	ADJ
egc-304	11	16	people	people	NOUN
egc-304	11	17	at	at	ADP
egc-304	11	18	risk	risk	NOUN
egc-304	11	19	of	of	ADP
egc-304	11	20	developing	develop	VERB
egc-304	11	21	cvd	cvd	PROPN
egc-304	11	22	,	,	PUNCT
egc-304	11	23	showed	show	VERB
egc-304	11	24	that	that	SCONJ
egc-304	11	25	normalization	normalization	NOUN
egc-304	11	26	of	of	ADP
egc-304	11	27	25(oh)d	25(oh)d	NUM
egc-304	11	28	levels	level	NOUN
egc-304	11	29	is	be	AUX
egc-304	11	30	associated	associate	VERB
egc-304	11	31	with	with	ADP
egc-304	11	32	a	a	DET
egc-304	11	33	reduced	reduced	ADJ
egc-304	11	34	risk	risk	NOUN
egc-304	11	35	of	of	ADP
egc-304	11	36	developing	develop	VERB
egc-304	11	37	ao	ao	NOUN
egc-304	11	38	,	,	PUNCT
egc-304	11	39	carbohydrate	carbohydrate	VERB
egc-304	11	40	metabolism	metabolism	NOUN
egc-304	11	41	disorders	disorder	NOUN
egc-304	11	42	and	and	CCONJ
egc-304	11	43	lipid	lipid	NOUN
egc-304	11	44	metabolism	metabolism	NOUN
egc-304	11	45	disorders	disorder	NOUN
egc-304	11	46	(	(	PUNCT
egc-304	11	47	a	a	DET
egc-304	11	48	decrease	decrease	NOUN
egc-304	11	49	in	in	ADP
egc-304	11	50	the	the	DET
egc-304	11	51	level	level	NOUN
egc-304	11	52	of	of	ADP
egc-304	11	53	highdensity	highdensity	NOUN
egc-304	11	54	lipoprotein	lipoprotein	ADJ
egc-304	11	55	cholesterol	cholesterol	NOUN
egc-304	11	56	(	(	PUNCT
egc-304	11	57	hdl	hdl	NOUN
egc-304	11	58	-	-	PUNCT
egc-304	11	59	c	c	NOUN
egc-304	11	60	)	)	PUNCT
egc-304	11	61	)	)	PUNCT
egc-304	11	62	regardless	regardless	ADV
egc-304	11	63	of	of	ADP
egc-304	11	64	age	age	NOUN
egc-304	11	65	,	,	PUNCT
egc-304	11	66	gender	gender	NOUN
egc-304	11	67	,	,	PUNCT
egc-304	11	68	race	race	NOUN
egc-304	11	69	[	[	X
egc-304	11	70	3	3	NUM
egc-304	11	71	]	]	PUNCT
egc-304	11	72	.	.	PUNCT
egc-304	12	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	12	2	mailto:gulchehra.kh@ya.ru	mailto:gulchehra.kh@ya.ru	NUM
egc-304	12	3	eglobal	eglobal	PROPN
egc-304	12	4	congress	congress	PROPN
egc-304	12	5	hosted	host	VERB
egc-304	12	6	online	online	ADV
egc-304	12	7	from	from	ADP
egc-304	12	8	dubai	dubai	PROPN
egc-304	12	9	,	,	PUNCT
egc-304	12	10	u.	u.	PROPN
egc-304	12	11	a.	a.	PROPN
egc-304	12	12	e.	e.	PROPN
egc-304	12	13	,	,	PUNCT
egc-304	12	14	e	e	PROPN
egc-304	12	15	conference	conference	NOUN
egc-304	12	16	.	.	PUNCT
egc-304	13	1	date	date	NOUN
egc-304	13	2	:	:	PUNCT
egc-304	13	3	30th	30th	ADJ
egc-304	13	4	january	january	PROPN
egc-304	13	5	2025	2025	NUM
egc-304	13	6	website	website	NOUN
egc-304	13	7	:	:	PUNCT
egc-304	13	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	13	9	issn	issn	PROPN
egc-304	13	10	(	(	PUNCT
egc-304	13	11	e	e	NOUN
egc-304	13	12	):	):	PUNCT
egc-304	13	13	2836	2836	NUM
egc-304	13	14	-	-	SYM
egc-304	13	15	3612	3612	NUM
egc-304	13	16	45	45	NUM
egc-304	13	17	|	|	ADV
egc-304	13	18	p	p	ADP
egc-304	13	19	a	a	DET
egc-304	13	20	g	g	NOUN
egc-304	13	21	e	e	NOUN
egc-304	13	22	objective	objective	NOUN
egc-304	13	23	to	to	PART
egc-304	13	24	study	study	VERB
egc-304	13	25	the	the	DET
egc-304	13	26	features	feature	NOUN
egc-304	13	27	of	of	ADP
egc-304	13	28	metabolic	metabolic	NOUN
egc-304	13	29	syndrome	syndrome	NOUN
egc-304	13	30	in	in	ADP
egc-304	13	31	women	woman	NOUN
egc-304	13	32	with	with	ADP
egc-304	13	33	vitamin	vitamin	NOUN
egc-304	13	34	d	d	NOUN
egc-304	13	35	deficiency	deficiency	NOUN
egc-304	13	36	,	,	PUNCT
egc-304	13	37	and	and	CCONJ
egc-304	13	38	to	to	PART
egc-304	13	39	evaluate	evaluate	VERB
egc-304	13	40	the	the	DET
egc-304	13	41	relationship	relationship	NOUN
egc-304	13	42	of	of	ADP
egc-304	13	43	metabolic	metabolic	NOUN
egc-304	13	44	syndrome	syndrome	NOUN
egc-304	13	45	with	with	ADP
egc-304	13	46	some	some	DET
egc-304	13	47	polymorphisms	polymorphism	NOUN
egc-304	13	48	of	of	ADP
egc-304	13	49	the	the	DET
egc-304	13	50	vdr	vdr	NOUN
egc-304	13	51	gene	gene	NOUN
egc-304	13	52	.	.	PUNCT
egc-304	14	1	materials	material	NOUN
egc-304	14	2	and	and	CCONJ
egc-304	14	3	methods	method	NOUN
egc-304	14	4	a	a	DET
egc-304	14	5	total	total	NOUN
egc-304	14	6	of	of	ADP
egc-304	14	7	120	120	NUM
egc-304	14	8	patients	patient	NOUN
egc-304	14	9	with	with	ADP
egc-304	14	10	metabolic	metabolic	NOUN
egc-304	14	11	syndrome	syndrome	NOUN
egc-304	14	12	aged	aged	ADJ
egc-304	14	13	18	18	NUM
egc-304	14	14	to	to	PART
egc-304	14	15	50	50	NUM
egc-304	14	16	years	year	NOUN
egc-304	14	17	were	be	AUX
egc-304	14	18	examined	examine	VERB
egc-304	14	19	,	,	PUNCT
egc-304	14	20	which	which	PRON
egc-304	14	21	formed	form	VERB
egc-304	14	22	the	the	DET
egc-304	14	23	main	main	ADJ
egc-304	14	24	study	study	NOUN
egc-304	14	25	group	group	NOUN
egc-304	14	26	.	.	PUNCT
egc-304	15	1	all	all	DET
egc-304	15	2	patients	patient	NOUN
egc-304	15	3	were	be	AUX
egc-304	15	4	assessed	assess	VERB
egc-304	15	5	for	for	ADP
egc-304	15	6	total	total	ADJ
egc-304	15	7	cholesterol	cholesterol	NOUN
egc-304	15	8	(	(	PUNCT
egc-304	15	9	tc	tc	NOUN
egc-304	15	10	)	)	PUNCT
egc-304	15	11	,	,	PUNCT
egc-304	15	12	triglycerides	triglyceride	NOUN
egc-304	15	13	(	(	PUNCT
egc-304	15	14	tg	tg	NOUN
egc-304	15	15	)	)	PUNCT
egc-304	15	16	,	,	PUNCT
egc-304	15	17	high	high	ADJ
egc-304	15	18	-	-	PUNCT
egc-304	15	19	density	density	NOUN
egc-304	15	20	lipoproteins	lipoprotein	NOUN
egc-304	15	21	(	(	PUNCT
egc-304	15	22	hdl	hdl	NOUN
egc-304	15	23	)	)	PUNCT
egc-304	15	24	,	,	PUNCT
egc-304	15	25	low	low	ADJ
egc-304	15	26	-	-	PUNCT
egc-304	15	27	density	density	NOUN
egc-304	15	28	lipoproteins	lipoprotein	NOUN
egc-304	15	29	(	(	PUNCT
egc-304	15	30	ldl	ldl	NOUN
egc-304	15	31	)	)	PUNCT
egc-304	15	32	,	,	PUNCT
egc-304	15	33	atherogenicity	atherogenicity	NOUN
egc-304	15	34	index	index	PROPN
egc-304	15	35	,	,	PUNCT
egc-304	15	36	fat	fat	ADJ
egc-304	15	37	mass	mass	NOUN
egc-304	15	38	(	(	PUNCT
egc-304	15	39	kg	kg	NOUN
egc-304	15	40	)	)	PUNCT
egc-304	15	41	,	,	PUNCT
egc-304	15	42	skeletal	skeletal	ADJ
egc-304	15	43	muscle	muscle	NOUN
egc-304	15	44	mass	mass	NOUN
egc-304	15	45	(	(	PUNCT
egc-304	15	46	kg	kg	NOUN
egc-304	15	47	)	)	PUNCT
egc-304	15	48	by	by	ADP
egc-304	15	49	bioimpedance	bioimpedance	NOUN
egc-304	15	50	analysis	analysis	NOUN
egc-304	15	51	of	of	ADP
egc-304	15	52	body	body	NOUN
egc-304	15	53	composition	composition	NOUN
egc-304	15	54	.	.	PUNCT
egc-304	16	1	body	body	NOUN
egc-304	16	2	weight	weight	NOUN
egc-304	16	3	was	be	AUX
egc-304	16	4	assessed	assess	VERB
egc-304	16	5	according	accord	VERB
egc-304	16	6	to	to	ADP
egc-304	16	7	the	the	DET
egc-304	16	8	quetelet	quetelet	ADJ
egc-304	16	9	body	body	NOUN
egc-304	16	10	mass	mass	NOUN
egc-304	16	11	index	index	NOUN
egc-304	16	12	with	with	ADP
egc-304	16	13	additional	additional	ADJ
egc-304	16	14	diagnostics	diagnostic	NOUN
egc-304	16	15	of	of	ADP
egc-304	16	16	abdominal	abdominal	ADJ
egc-304	16	17	obesity	obesity	NOUN
egc-304	16	18	,	,	PUNCT
egc-304	16	19	leading	lead	VERB
egc-304	16	20	symptoms	symptom	NOUN
egc-304	16	21	of	of	ADP
egc-304	16	22	insulin	insulin	NOUN
egc-304	16	23	resistance	resistance	NOUN
egc-304	16	24	(	(	PUNCT
egc-304	16	25	acanthosis	acanthosis	NOUN
egc-304	16	26	nigricans	nigrican	NOUN
egc-304	16	27	of	of	ADP
egc-304	16	28	skin	skin	NOUN
egc-304	16	29	folds	fold	NOUN
egc-304	16	30	,	,	PUNCT
egc-304	16	31	papillomatosis	papillomatosis	NOUN
egc-304	16	32	,	,	PUNCT
egc-304	16	33	vascular	vascular	ADJ
egc-304	16	34	angiomas	angioma	NOUN
egc-304	16	35	)	)	PUNCT
egc-304	16	36	in	in	ADP
egc-304	16	37	accordance	accordance	NOUN
egc-304	16	38	with	with	ADP
egc-304	16	39	the	the	DET
egc-304	16	40	current	current	NOUN
egc-304	16	41	who	who	PRON
egc-304	16	42	criteria	criteria	VERB
egc-304	16	43	.	.	PUNCT
egc-304	17	1	levels	level	NOUN
egc-304	17	2	of	of	ADP
egc-304	17	3	vitamin	vitamin	NOUN
egc-304	17	4	d	d	NOUN
egc-304	17	5	metabolites	metabolite	NOUN
egc-304	17	6	25(oh)d	25(oh)d	NOUN
egc-304	17	7	and	and	CCONJ
egc-304	17	8	the	the	DET
egc-304	17	9	presence	presence	NOUN
egc-304	17	10	of	of	ADP
egc-304	17	11	vdr	vdr	NOUN
egc-304	17	12	gene	gene	NOUN
egc-304	17	13	polymorphisms	polymorphism	NOUN
egc-304	17	14	(	(	PUNCT
egc-304	17	15	foklvdr	foklvdr	VERB
egc-304	17	16	rs10735810	rs10735810	PROPN
egc-304	17	17	,	,	PUNCT
egc-304	17	18	apal	apal	ADJ
egc-304	17	19	vdr	vdr	PROPN
egc-304	17	20	rs7975232	rs7975232	PROPN
egc-304	17	21	)	)	PUNCT
egc-304	17	22	were	be	AUX
egc-304	17	23	determined	determine	VERB
egc-304	17	24	in	in	ADP
egc-304	17	25	blood	blood	NOUN
egc-304	17	26	serum	serum	NOUN
egc-304	17	27	.	.	PUNCT
egc-304	18	1	results	result	VERB
egc-304	18	2	the	the	DET
egc-304	18	3	results	result	NOUN
egc-304	18	4	of	of	ADP
egc-304	18	5	fundamental	fundamental	ADJ
egc-304	18	6	and	and	CCONJ
egc-304	18	7	clinical	clinical	ADJ
egc-304	18	8	studies	study	NOUN
egc-304	18	9	have	have	AUX
egc-304	18	10	shown	show	VERB
egc-304	18	11	that	that	SCONJ
egc-304	18	12	ms	ms	PROPN
egc-304	18	13	is	be	AUX
egc-304	18	14	associated	associate	VERB
egc-304	18	15	with	with	ADP
egc-304	18	16	deficiencies	deficiency	NOUN
egc-304	18	17	of	of	ADP
egc-304	18	18	various	various	ADJ
egc-304	18	19	micronutrients	micronutrient	NOUN
egc-304	18	20	:	:	PUNCT
egc-304	18	21	magnesium	magnesium	NOUN
egc-304	18	22	,	,	PUNCT
egc-304	18	23	vitamin	vitamin	NOUN
egc-304	18	24	d	d	NOUN
egc-304	18	25	and	and	CCONJ
egc-304	18	26	myoinositol	myoinositol	NOUN
egc-304	19	1	[	[	X
egc-304	19	2	12	12	NUM
egc-304	19	3	]	]	PUNCT
egc-304	19	4	.	.	PUNCT
egc-304	20	1	a	a	DET
egc-304	20	2	relationship	relationship	NOUN
egc-304	20	3	has	have	AUX
egc-304	20	4	also	also	ADV
egc-304	20	5	been	be	AUX
egc-304	20	6	established	establish	VERB
egc-304	20	7	between	between	ADP
egc-304	20	8	the	the	DET
egc-304	20	9	presence	presence	NOUN
egc-304	20	10	of	of	ADP
egc-304	20	11	vdr	vdr	NOUN
egc-304	20	12	gene	gene	NOUN
egc-304	20	13	polymorphisms	polymorphism	NOUN
egc-304	20	14	(	(	PUNCT
egc-304	20	15	foklvdr	foklvdr	VERB
egc-304	20	16	rs10735810	rs10735810	PROPN
egc-304	20	17	,	,	PUNCT
egc-304	20	18	apal	apal	ADJ
egc-304	20	19	vdr	vdr	NOUN
egc-304	20	20	rs7975232	rs7975232	PROPN
egc-304	20	21	)	)	PUNCT
egc-304	20	22	and	and	CCONJ
egc-304	20	23	the	the	DET
egc-304	20	24	severity	severity	NOUN
egc-304	20	25	of	of	ADP
egc-304	20	26	the	the	DET
egc-304	20	27	clinical	clinical	ADJ
egc-304	20	28	picture	picture	NOUN
egc-304	20	29	of	of	ADP
egc-304	20	30	metabolic	metabolic	NOUN
egc-304	20	31	syndrome	syndrome	NOUN
egc-304	20	32	.	.	PUNCT
egc-304	21	1	vitamin	vitamin	NOUN
egc-304	21	2	d	d	NOUN
egc-304	21	3	and	and	CCONJ
egc-304	21	4	myoinositol	myoinositol	ADJ
egc-304	21	5	deficiencies	deficiency	NOUN
egc-304	21	6	,	,	PUNCT
egc-304	21	7	especially	especially	ADV
egc-304	21	8	combined	combine	VERB
egc-304	21	9	ones	one	NOUN
egc-304	21	10	,	,	PUNCT
egc-304	21	11	stimulate	stimulate	VERB
egc-304	21	12	the	the	DET
egc-304	21	13	development	development	NOUN
egc-304	21	14	of	of	ADP
egc-304	21	15	such	such	ADJ
egc-304	21	16	ms	ms	PROPN
egc-304	21	17	components	component	NOUN
egc-304	21	18	as	as	ADP
egc-304	21	19	impaired	impaired	ADJ
egc-304	21	20	glucose	glucose	NOUN
egc-304	21	21	tolerance	tolerance	NOUN
egc-304	21	22	,	,	PUNCT
egc-304	21	23	dyslipidemia	dyslipidemia	NOUN
egc-304	21	24	and	and	CCONJ
egc-304	21	25	abdominal	abdominal	ADJ
egc-304	21	26	obesity	obesity	NOUN
egc-304	21	27	.	.	PUNCT
egc-304	22	1	in	in	ADP
egc-304	22	2	the	the	DET
egc-304	22	3	examined	examine	VERB
egc-304	22	4	patients	patient	NOUN
egc-304	22	5	with	with	ADP
egc-304	22	6	ms	ms	PROPN
egc-304	22	7	,	,	PUNCT
egc-304	22	8	the	the	DET
egc-304	22	9	level	level	NOUN
egc-304	22	10	of	of	ADP
egc-304	22	11	25(oh)d	25(oh)d	NOUN
egc-304	22	12	in	in	ADP
egc-304	22	13	the	the	DET
egc-304	22	14	serum	serum	NOUN
egc-304	22	15	was	be	AUX
egc-304	22	16	16.4±4.4	16.4±4.4	NUM
egc-304	22	17	mmol	mmol	NOUN
egc-304	22	18	/	/	SYM
egc-304	22	19	l.	l.	NOUN
egc-304	22	20	at	at	ADP
egc-304	22	21	the	the	DET
egc-304	22	22	same	same	ADJ
egc-304	22	23	time	time	NOUN
egc-304	22	24	,	,	PUNCT
egc-304	22	25	deficiency	deficiency	NOUN
egc-304	22	26	or	or	CCONJ
egc-304	22	27	insufficient	insufficient	ADJ
egc-304	22	28	level	level	NOUN
egc-304	22	29	of	of	ADP
egc-304	22	30	25(oh)d	25(oh)d	NOUN
egc-304	22	31	,	,	PUNCT
egc-304	22	32	as	as	ADV
egc-304	22	33	well	well	ADV
egc-304	22	34	as	as	ADP
egc-304	22	35	vdr	vdr	NOUN
egc-304	22	36	gene	gene	NOUN
egc-304	22	37	polymorphism	polymorphism	NOUN
egc-304	22	38	were	be	AUX
egc-304	22	39	found	find	VERB
egc-304	22	40	in	in	ADP
egc-304	22	41	90	90	NUM
egc-304	22	42	out	out	ADP
egc-304	22	43	of	of	ADP
egc-304	22	44	120	120	NUM
egc-304	22	45	patients	patient	NOUN
egc-304	22	46	(	(	PUNCT
egc-304	22	47	75.3	75.3	NUM
egc-304	22	48	%	%	NOUN
egc-304	22	49	of	of	ADP
egc-304	22	50	patients	patient	NOUN
egc-304	22	51	)	)	PUNCT
egc-304	22	52	.	.	PUNCT
egc-304	23	1	we	we	PRON
egc-304	23	2	identified	identify	VERB
egc-304	23	3	the	the	DET
egc-304	23	4	following	follow	VERB
egc-304	23	5	relationships	relationship	NOUN
egc-304	23	6	between	between	ADP
egc-304	23	7	low	low	ADJ
egc-304	23	8	25(oh	25(oh	NOUN
egc-304	23	9	)	)	PUNCT
egc-304	23	10	vitamin	vitamin	NOUN
egc-304	23	11	d	d	NOUN
egc-304	23	12	values	value	NOUN
egc-304	23	13	,	,	PUNCT
egc-304	23	14	the	the	DET
egc-304	23	15	presence	presence	NOUN
egc-304	23	16	of	of	ADP
egc-304	23	17	vdr	vdr	NOUN
egc-304	23	18	gene	gene	NOUN
egc-304	23	19	polymorphisms	polymorphism	NOUN
egc-304	23	20	and	and	CCONJ
egc-304	23	21	a	a	DET
egc-304	23	22	number	number	NOUN
egc-304	23	23	of	of	ADP
egc-304	23	24	characteristics	characteristic	NOUN
egc-304	23	25	of	of	ADP
egc-304	23	26	patients	patient	NOUN
egc-304	23	27	with	with	ADP
egc-304	23	28	ms	ms	PROPN
egc-304	23	29	.	.	PROPN
egc-304	23	30	the	the	DET
egc-304	23	31	level	level	NOUN
egc-304	23	32	of	of	ADP
egc-304	23	33	25(oh)d	25(oh)d	NOUN
egc-304	23	34	in	in	ADP
egc-304	23	35	serum	serum	NOUN
egc-304	23	36	directly	directly	ADV
egc-304	23	37	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	ADJ
egc-304	23	38	eglobal	eglobal	PROPN
egc-304	23	39	congress	congress	PROPN
egc-304	23	40	hosted	host	VERB
egc-304	23	41	online	online	ADV
egc-304	23	42	from	from	ADP
egc-304	23	43	dubai	dubai	PROPN
egc-304	23	44	,	,	PUNCT
egc-304	23	45	u.	u.	PROPN
egc-304	23	46	a.	a.	PROPN
egc-304	23	47	e.	e.	PROPN
egc-304	23	48	,	,	PUNCT
egc-304	23	49	e	e	PROPN
egc-304	23	50	conference	conference	NOUN
egc-304	23	51	.	.	PUNCT
egc-304	24	1	date	date	NOUN
egc-304	24	2	:	:	PUNCT
egc-304	24	3	30th	30th	ADJ
egc-304	24	4	january	january	PROPN
egc-304	24	5	2025	2025	NUM
egc-304	24	6	website	website	NOUN
egc-304	24	7	:	:	PUNCT
egc-304	24	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	24	9	issn	issn	PROPN
egc-304	24	10	(	(	PUNCT
egc-304	24	11	e	e	NOUN
egc-304	24	12	):	):	PUNCT
egc-304	24	13	2836	2836	NUM
egc-304	24	14	-	-	SYM
egc-304	24	15	3612	3612	NUM
egc-304	24	16	46	46	NUM
egc-304	24	17	|	|	ADV
egc-304	24	18	p	p	ADP
egc-304	24	19	a	a	DET
egc-304	24	20	g	g	NOUN
egc-304	24	21	e	e	NOUN
egc-304	24	22	correlated	correlate	VERB
egc-304	24	23	with	with	ADP
egc-304	24	24	the	the	DET
egc-304	24	25	presence	presence	NOUN
egc-304	24	26	of	of	ADP
egc-304	24	27	hypertension	hypertension	NOUN
egc-304	24	28	(	(	PUNCT
egc-304	24	29	r=-0.41	r=-0.41	NUM
egc-304	24	30	;	;	PUNCT
egc-304	24	31	p=0.017	p=0.017	X
egc-304	24	32	)	)	PUNCT
egc-304	24	33	and	and	CCONJ
egc-304	24	34	with	with	ADP
egc-304	24	35	the	the	DET
egc-304	24	36	level	level	NOUN
egc-304	24	37	of	of	ADP
egc-304	24	38	triglycerides	triglyceride	NOUN
egc-304	24	39	and	and	CCONJ
egc-304	24	40	low	low	ADJ
egc-304	24	41	-	-	PUNCT
egc-304	24	42	density	density	NOUN
egc-304	24	43	lipoproteins	lipoprotein	NOUN
egc-304	24	44	(	(	PUNCT
egc-304	24	45	r=-0.29	r=-0.29	NOUN
egc-304	24	46	;	;	PUNCT
egc-304	24	47	p=0.038	p=0.038	NOUN
egc-304	24	48	)	)	PUNCT
egc-304	24	49	,	,	PUNCT
egc-304	24	50	highdensity	highdensity	NOUN
egc-304	24	51	lipoproteins	lipoprotein	NOUN
egc-304	24	52	(	(	PUNCT
egc-304	24	53	r=0.2	r=0.2	NOUN
egc-304	24	54	;	;	PUNCT
egc-304	24	55	p=0.031	p=0.031	NUM
egc-304	24	56	)	)	PUNCT
egc-304	24	57	,	,	PUNCT
egc-304	24	58	fat	fat	ADJ
egc-304	24	59	mass	mass	NOUN
egc-304	24	60	(	(	PUNCT
egc-304	24	61	kg	kg	NOUN
egc-304	24	62	)	)	PUNCT
egc-304	24	63	(	(	PUNCT
egc-304	24	64	r=0.23	r=0.23	NOUN
egc-304	24	65	;	;	PUNCT
egc-304	24	66	p=0.034	p=0.034	NUM
egc-304	24	67	)	)	PUNCT
egc-304	24	68	.	.	PUNCT
egc-304	25	1	when	when	SCONJ
egc-304	25	2	comparing	compare	VERB
egc-304	25	3	the	the	DET
egc-304	25	4	indicators	indicator	NOUN
egc-304	25	5	in	in	ADP
egc-304	25	6	the	the	DET
egc-304	25	7	groups	group	NOUN
egc-304	25	8	,	,	PUNCT
egc-304	25	9	it	it	PRON
egc-304	25	10	was	be	AUX
egc-304	25	11	revealed	reveal	VERB
egc-304	25	12	that	that	SCONJ
egc-304	25	13	lower	low	ADJ
egc-304	25	14	values	value	NOUN
egc-304	25	15	of	of	ADP
egc-304	25	16	25(oh)d	25(oh)d	NOUN
egc-304	25	17	were	be	AUX
egc-304	25	18	observed	observe	VERB
egc-304	25	19	in	in	ADP
egc-304	25	20	patients	patient	NOUN
egc-304	25	21	with	with	ADP
egc-304	25	22	high	high	ADJ
egc-304	25	23	insulin	insulin	NOUN
egc-304	25	24	and	and	CCONJ
egc-304	25	25	the	the	DET
egc-304	25	26	severity	severity	NOUN
egc-304	25	27	of	of	ADP
egc-304	25	28	clinical	clinical	ADJ
egc-304	25	29	manifestations	manifestation	NOUN
egc-304	25	30	(	(	PUNCT
egc-304	25	31	acanthosis	acanthosis	NOUN
egc-304	25	32	nigricans	nigrican	NOUN
egc-304	25	33	,	,	PUNCT
egc-304	25	34	papillomatosis	papillomatosis	NOUN
egc-304	25	35	,	,	PUNCT
egc-304	25	36	vascular	vascular	ADJ
egc-304	25	37	angiomas	angioma	NOUN
egc-304	25	38	)	)	PUNCT
egc-304	25	39	and	and	CCONJ
egc-304	25	40	the	the	DET
egc-304	25	41	homa	homa	PROPN
egc-304	25	42	index	index	NOUN
egc-304	25	43	(	(	PUNCT
egc-304	25	44	p=0.013	p=0.013	NOUN
egc-304	25	45	)	)	PUNCT
egc-304	25	46	and	and	CCONJ
egc-304	25	47	with	with	ADP
egc-304	25	48	the	the	DET
egc-304	25	49	presence	presence	NOUN
egc-304	25	50	of	of	ADP
egc-304	25	51	obesity	obesity	NOUN
egc-304	25	52	of	of	ADP
egc-304	25	53	the	the	DET
egc-304	25	54	3rd	3rd	ADJ
egc-304	25	55	and	and	CCONJ
egc-304	25	56	4th	4th	ADJ
egc-304	25	57	degrees	degree	NOUN
egc-304	25	58	(	(	PUNCT
egc-304	25	59	r=-0.47	r=-0.47	NOUN
egc-304	25	60	;	;	PUNCT
egc-304	25	61	p=0.029	p=0.029	X
egc-304	25	62	)	)	PUNCT
egc-304	25	63	.	.	PUNCT
egc-304	26	1	conclusions	conclusion	NOUN
egc-304	26	2	vitamin	vitamin	NOUN
egc-304	26	3	d	d	NOUN
egc-304	26	4	insufficiency	insufficiency	NOUN
egc-304	26	5	and	and	CCONJ
egc-304	26	6	deficiency	deficiency	NOUN
egc-304	26	7	and	and	CCONJ
egc-304	26	8	the	the	DET
egc-304	26	9	presence	presence	NOUN
egc-304	26	10	of	of	ADP
egc-304	26	11	vdr	vdr	NOUN
egc-304	26	12	gene	gene	NOUN
egc-304	26	13	polymorphisms	polymorphism	NOUN
egc-304	26	14	(	(	PUNCT
egc-304	26	15	foklvdr	foklvdr	VERB
egc-304	26	16	rs10735810	rs10735810	PROPN
egc-304	26	17	,	,	PUNCT
egc-304	26	18	apal	apal	ADJ
egc-304	26	19	vdr	vdr	PROPN
egc-304	26	20	rs7975232	rs7975232	PROPN
egc-304	26	21	)	)	PUNCT
egc-304	26	22	correlate	correlate	VERB
egc-304	26	23	with	with	ADP
egc-304	26	24	the	the	DET
egc-304	26	25	main	main	ADJ
egc-304	26	26	pathological	pathological	ADJ
egc-304	26	27	changes	change	NOUN
egc-304	26	28	in	in	ADP
egc-304	26	29	metabolic	metabolic	NOUN
egc-304	26	30	syndrome	syndrome	NOUN
egc-304	26	31	,	,	PUNCT
egc-304	26	32	such	such	ADJ
egc-304	26	33	as	as	ADP
egc-304	26	34	arterial	arterial	ADJ
egc-304	26	35	hypertension	hypertension	NOUN
egc-304	26	36	,	,	PUNCT
egc-304	26	37	dyslipidemia	dyslipidemia	NOUN
egc-304	26	38	,	,	PUNCT
egc-304	26	39	insulin	insulin	NOUN
egc-304	26	40	resistance	resistance	NOUN
egc-304	26	41	,	,	PUNCT
egc-304	26	42	decreased	decrease	VERB
egc-304	26	43	skeletal	skeletal	ADJ
egc-304	26	44	muscle	muscle	NOUN
egc-304	26	45	mass	mass	NOUN
egc-304	26	46	,	,	PUNCT
egc-304	26	47	abdominal	abdominal	ADJ
egc-304	26	48	obesity	obesity	NOUN
egc-304	26	49	.	.	PUNCT
egc-304	27	1	from	from	ADP
egc-304	27	2	a	a	DET
egc-304	27	3	practical	practical	ADJ
egc-304	27	4	point	point	NOUN
egc-304	27	5	of	of	ADP
egc-304	27	6	view	view	NOUN
egc-304	27	7	,	,	PUNCT
egc-304	27	8	it	it	PRON
egc-304	27	9	is	be	AUX
egc-304	27	10	advisable	advisable	ADJ
egc-304	27	11	to	to	PART
egc-304	27	12	determine	determine	VERB
egc-304	27	13	the	the	DET
egc-304	27	14	level	level	NOUN
egc-304	27	15	of	of	ADP
egc-304	27	16	vitamin	vitamin	NOUN
egc-304	27	17	d	d	NOUN
egc-304	27	18	and	and	CCONJ
egc-304	27	19	the	the	DET
egc-304	27	20	presence	presence	NOUN
egc-304	27	21	of	of	ADP
egc-304	27	22	vdr	vdr	NOUN
egc-304	27	23	gene	gene	NOUN
egc-304	27	24	polymorphisms	polymorphism	NOUN
egc-304	27	25	in	in	ADP
egc-304	27	26	the	the	DET
egc-304	27	27	blood	blood	NOUN
egc-304	27	28	serum	serum	NOUN
egc-304	27	29	of	of	ADP
egc-304	27	30	patients	patient	NOUN
egc-304	27	31	with	with	ADP
egc-304	27	32	metabolic	metabolic	NOUN
egc-304	27	33	syndrome	syndrome	NOUN
egc-304	27	34	,	,	PUNCT
egc-304	27	35	determine	determine	VERB
egc-304	27	36	the	the	DET
egc-304	27	37	level	level	NOUN
egc-304	27	38	of	of	ADP
egc-304	27	39	fat	fat	ADJ
egc-304	27	40	mass	mass	NOUN
egc-304	27	41	and	and	CCONJ
egc-304	27	42	skeletal	skeletal	ADJ
egc-304	27	43	muscle	muscle	NOUN
egc-304	27	44	mass	mass	NOUN
egc-304	27	45	using	use	VERB
egc-304	27	46	the	the	DET
egc-304	27	47	method	method	NOUN
egc-304	27	48	of	of	ADP
egc-304	27	49	bioimpedance	bioimpedance	NOUN
egc-304	27	50	analysis	analysis	NOUN
egc-304	27	51	of	of	ADP
egc-304	27	52	body	body	NOUN
egc-304	27	53	composition	composition	NOUN
egc-304	27	54	and	and	CCONJ
egc-304	27	55	,	,	PUNCT
egc-304	27	56	accordingly	accordingly	ADV
egc-304	27	57	,	,	PUNCT
egc-304	27	58	in	in	ADP
egc-304	27	59	case	case	NOUN
egc-304	27	60	of	of	ADP
egc-304	27	61	vitamin	vitamin	NOUN
egc-304	27	62	d	d	NOUN
egc-304	27	63	deficiency	deficiency	NOUN
egc-304	27	64	,	,	PUNCT
egc-304	27	65	carry	carry	VERB
egc-304	27	66	out	out	ADP
egc-304	27	67	correction	correction	NOUN
egc-304	27	68	in	in	ADP
egc-304	27	69	a	a	DET
egc-304	27	70	dose	dose	NOUN
egc-304	27	71	of	of	ADP
egc-304	27	72	5,000	5,000	NUM
egc-304	27	73	iu	iu	NOUN
egc-304	27	74	to	to	ADP
egc-304	27	75	10,000	10,000	NUM
egc-304	27	76	iu	iu	ADP
egc-304	27	77	per	per	ADP
egc-304	27	78	day	day	NOUN
egc-304	27	79	.	.	PUNCT
egc-304	28	1	accordingly	accordingly	ADV
egc-304	28	2	,	,	PUNCT
egc-304	28	3	compensation	compensation	NOUN
egc-304	28	4	for	for	ADP
egc-304	28	5	vitamin	vitamin	NOUN
egc-304	28	6	d	d	NOUN
egc-304	28	7	deficiency	deficiency	NOUN
egc-304	28	8	improves	improve	VERB
egc-304	28	9	metabolic	metabolic	NOUN
egc-304	28	10	control	control	NOUN
egc-304	28	11	.	.	PUNCT
egc-304	29	1	the	the	DET
egc-304	29	2	study	study	NOUN
egc-304	29	3	of	of	ADP
egc-304	29	4	polymorphisms	polymorphism	NOUN
egc-304	29	5	of	of	ADP
egc-304	29	6	genes	gene	NOUN
egc-304	29	7	involved	involve	VERB
egc-304	29	8	in	in	ADP
egc-304	29	9	lipid	lipid	ADJ
egc-304	29	10	metabolism	metabolism	NOUN
egc-304	29	11	,	,	PUNCT
egc-304	29	12	genes	gene	NOUN
egc-304	29	13	regulating	regulate	VERB
egc-304	29	14	eating	eat	VERB
egc-304	29	15	behavior	behavior	NOUN
egc-304	29	16	is	be	AUX
egc-304	29	17	applicable	applicable	ADJ
egc-304	29	18	for	for	ADP
egc-304	29	19	the	the	DET
egc-304	29	20	development	development	NOUN
egc-304	29	21	of	of	ADP
egc-304	29	22	personalized	personalized	ADJ
egc-304	29	23	programs	program	NOUN
egc-304	29	24	for	for	ADP
egc-304	29	25	safe	safe	ADJ
egc-304	29	26	weight	weight	NOUN
egc-304	29	27	loss	loss	NOUN
egc-304	29	28	,	,	PUNCT
egc-304	29	29	including	include	VERB
egc-304	29	30	individual	individual	ADJ
egc-304	29	31	diets	diet	NOUN
egc-304	29	32	and	and	CCONJ
egc-304	29	33	physical	physical	ADJ
egc-304	29	34	activity	activity	NOUN
egc-304	29	35	.	.	PUNCT
egc-304	30	1	this	this	DET
egc-304	30	2	approach	approach	NOUN
egc-304	30	3	increases	increase	VERB
egc-304	30	4	patient	patient	ADJ
egc-304	30	5	compliance	compliance	NOUN
egc-304	30	6	.	.	PUNCT
egc-304	31	1	analysis	analysis	NOUN
egc-304	31	2	of	of	ADP
egc-304	31	3	molecular	molecular	ADJ
egc-304	31	4	genetic	genetic	ADJ
egc-304	31	5	and	and	CCONJ
egc-304	31	6	metabolic	metabolic	NOUN
egc-304	31	7	profiles	profile	NOUN
egc-304	31	8	of	of	ADP
egc-304	31	9	patients	patient	NOUN
egc-304	31	10	can	can	AUX
egc-304	31	11	become	become	VERB
egc-304	31	12	part	part	NOUN
egc-304	31	13	of	of	ADP
egc-304	31	14	the	the	DET
egc-304	31	15	prevention	prevention	NOUN
egc-304	31	16	of	of	ADP
egc-304	31	17	cardiovascular	cardiovascular	ADJ
egc-304	31	18	and	and	CCONJ
egc-304	31	19	endocrine	endocrine	ADJ
egc-304	31	20	complications	complication	NOUN
egc-304	31	21	.	.	PUNCT
egc-304	32	1	inositols	inositol	NOUN
egc-304	32	2	in	in	ADP
egc-304	32	3	combination	combination	NOUN
egc-304	32	4	with	with	ADP
egc-304	32	5	metformin	metformin	NOUN
egc-304	32	6	can	can	AUX
egc-304	32	7	act	act	VERB
egc-304	32	8	as	as	ADP
egc-304	32	9	synergists	synergist	NOUN
egc-304	32	10	,	,	PUNCT
egc-304	32	11	which	which	PRON
egc-304	32	12	allows	allow	VERB
egc-304	32	13	for	for	ADP
egc-304	32	14	a	a	DET
egc-304	32	15	reduction	reduction	NOUN
egc-304	32	16	in	in	ADP
egc-304	32	17	the	the	DET
egc-304	32	18	metformin	metformin	PROPN
egc-304	32	19	dose	dose	PROPN
egc-304	32	20	,	,	PUNCT
egc-304	32	21	especially	especially	ADV
egc-304	32	22	in	in	ADP
egc-304	32	23	patients	patient	NOUN
egc-304	32	24	with	with	ADP
egc-304	32	25	poor	poor	ADJ
egc-304	32	26	tolerance	tolerance	NOUN
egc-304	32	27	.	.	PUNCT
egc-304	33	1	the	the	DET
egc-304	33	2	effectiveness	effectiveness	NOUN
egc-304	33	3	of	of	ADP
egc-304	33	4	d	d	NOUN
egc-304	33	5	-	-	PUNCT
egc-304	33	6	chiroinositol	chiroinositol	NOUN
egc-304	33	7	in	in	ADP
egc-304	33	8	the	the	DET
egc-304	33	9	treatment	treatment	NOUN
egc-304	33	10	of	of	ADP
egc-304	33	11	women	woman	NOUN
egc-304	33	12	with	with	ADP
egc-304	33	13	metabolic	metabolic	NOUN
egc-304	33	14	syndrome	syndrome	NOUN
egc-304	33	15	is	be	AUX
egc-304	33	16	associated	associate	VERB
egc-304	33	17	with	with	ADP
egc-304	33	18	improved	improved	ADJ
egc-304	33	19	tissue	tissue	NOUN
egc-304	33	20	sensitivity	sensitivity	NOUN
egc-304	33	21	to	to	ADP
egc-304	33	22	insulin	insulin	NOUN
egc-304	33	23	and	and	CCONJ
egc-304	33	24	improved	improve	VERB
egc-304	33	25	ovulatory	ovulatory	ADJ
egc-304	33	26	function	function	NOUN
egc-304	33	27	,	,	PUNCT
egc-304	33	28	decreased	decrease	VERB
egc-304	33	29	serum	serum	NOUN
egc-304	33	30	androgen	androgen	NOUN
egc-304	33	31	concentrations	concentration	NOUN
egc-304	33	32	,	,	PUNCT
egc-304	33	33	decreased	decrease	VERB
egc-304	33	34	blood	blood	NOUN
egc-304	33	35	pressure	pressure	NOUN
egc-304	33	36	and	and	CCONJ
egc-304	33	37	tg	tg	PROPN
egc-304	33	38	concentrations	concentration	NOUN
egc-304	34	1	[	[	X
egc-304	34	2	4	4	NUM
egc-304	34	3	]	]	X
egc-304	34	4	.	.	PUNCT
egc-304	35	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	35	2	eglobal	eglobal	PROPN
egc-304	35	3	congress	congress	PROPN
egc-304	35	4	hosted	host	VERB
egc-304	35	5	online	online	ADV
egc-304	35	6	from	from	ADP
egc-304	35	7	dubai	dubai	PROPN
egc-304	35	8	,	,	PUNCT
egc-304	35	9	u.	u.	PROPN
egc-304	35	10	a.	a.	PROPN
egc-304	35	11	e.	e.	PROPN
egc-304	35	12	,	,	PUNCT
egc-304	35	13	e	e	PROPN
egc-304	35	14	conference	conference	NOUN
egc-304	35	15	.	.	PUNCT
egc-304	36	1	date	date	NOUN
egc-304	36	2	:	:	PUNCT
egc-304	36	3	30th	30th	ADJ
egc-304	36	4	january	january	PROPN
egc-304	36	5	2025	2025	NUM
egc-304	36	6	website	website	NOUN
egc-304	36	7	:	:	PUNCT
egc-304	36	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	36	9	issn	issn	PROPN
egc-304	36	10	(	(	PUNCT
egc-304	36	11	e	e	NOUN
egc-304	36	12	):	):	PUNCT
egc-304	36	13	2836	2836	NUM
egc-304	36	14	-	-	SYM
egc-304	36	15	3612	3612	NUM
egc-304	36	16	47	47	NUM
egc-304	37	1	|	|	ADV
egc-304	37	2	p	p	X
egc-304	37	3	a	a	DET
egc-304	37	4	g	g	NOUN
egc-304	37	5	e	e	NOUN
egc-304	37	6	reducing	reduce	VERB
egc-304	37	7	or	or	CCONJ
egc-304	37	8	eliminating	eliminate	VERB
egc-304	37	9	refined	refined	ADJ
egc-304	37	10	sugar	sugar	NOUN
egc-304	37	11	and	and	CCONJ
egc-304	37	12	simple	simple	ADJ
egc-304	37	13	carbohydrates	carbohydrate	NOUN
egc-304	37	14	,	,	PUNCT
egc-304	37	15	increasing	increase	VERB
egc-304	37	16	the	the	DET
egc-304	37	17	consumption	consumption	NOUN
egc-304	37	18	of	of	ADP
egc-304	37	19	complex	complex	ADJ
egc-304	37	20	carbohydrates	carbohydrate	NOUN
egc-304	37	21	and	and	CCONJ
egc-304	37	22	whole	whole	ADJ
egc-304	37	23	grains	grain	NOUN
egc-304	37	24	(	(	PUNCT
egc-304	37	25	oat	oat	NOUN
egc-304	37	26	,	,	PUNCT
egc-304	37	27	barley	barley	NOUN
egc-304	37	28	,	,	PUNCT
egc-304	37	29	wheat	wheat	NOUN
egc-304	37	30	)	)	PUNCT
egc-304	37	31	3	3	NUM
egc-304	37	32	-	-	SYM
egc-304	37	33	4	4	NUM
egc-304	37	34	times	time	NOUN
egc-304	37	35	a	a	DET
egc-304	37	36	week	week	NOUN
egc-304	37	37	,	,	PUNCT
egc-304	37	38	other	other	ADJ
egc-304	37	39	changes	change	NOUN
egc-304	37	40	in	in	ADP
egc-304	37	41	diet	diet	NOUN
egc-304	37	42	and	and	CCONJ
egc-304	37	43	lifestyle	lifestyle	NOUN
egc-304	37	44	that	that	PRON
egc-304	37	45	will	will	AUX
egc-304	37	46	have	have	VERB
egc-304	37	47	a	a	DET
egc-304	37	48	positive	positive	ADJ
egc-304	37	49	effect	effect	NOUN
egc-304	37	50	on	on	ADP
egc-304	37	51	glucose	glucose	NOUN
egc-304	37	52	and	and	CCONJ
egc-304	37	53	insulin	insulin	NOUN
egc-304	37	54	levels	level	NOUN
egc-304	37	55	can	can	AUX
egc-304	37	56	have	have	VERB
egc-304	37	57	a	a	DET
egc-304	37	58	positive	positive	ADJ
egc-304	37	59	effect	effect	NOUN
egc-304	37	60	on	on	ADP
egc-304	37	61	life	life	NOUN
egc-304	37	62	expectancy	expectancy	NOUN
egc-304	37	63	and	and	CCONJ
egc-304	37	64	reduce	reduce	VERB
egc-304	37	65	the	the	DET
egc-304	37	66	risk	risk	NOUN
egc-304	37	67	of	of	ADP
egc-304	37	68	chronic	chronic	ADJ
egc-304	37	69	diseases	disease	NOUN
egc-304	37	70	in	in	ADP
egc-304	37	71	women	woman	NOUN
egc-304	37	72	of	of	ADP
egc-304	37	73	childbearing	childbeare	VERB
egc-304	37	74	age	age	NOUN
egc-304	37	75	.	.	PUNCT
egc-304	38	1	in	in	ADP
egc-304	38	2	addition	addition	NOUN
egc-304	38	3	,	,	PUNCT
egc-304	38	4	regular	regular	ADJ
egc-304	38	5	(	(	PUNCT
egc-304	38	6	daily	daily	ADJ
egc-304	38	7	)	)	PUNCT
egc-304	38	8	40	40	NUM
egc-304	38	9	-	-	PUNCT
egc-304	38	10	minute	minute	NOUN
egc-304	38	11	walking	walking	NOUN
egc-304	38	12	per	per	ADP
egc-304	38	13	day	day	NOUN
egc-304	38	14	:	:	PUNCT
egc-304	38	15	burns	burn	VERB
egc-304	38	16	about	about	ADV
egc-304	38	17	100	100	NUM
egc-304	38	18	-	-	SYM
egc-304	38	19	120	120	NUM
egc-304	38	20	kcal	kcal	NOUN
egc-304	38	21	per	per	ADP
egc-304	38	22	day	day	NOUN
egc-304	38	23	;	;	PUNCT
egc-304	38	24	has	have	VERB
egc-304	38	25	a	a	DET
egc-304	38	26	vasodilatory	vasodilatory	ADJ
egc-304	38	27	effect	effect	NOUN
egc-304	38	28	;	;	PUNCT
egc-304	38	29	promotes	promote	VERB
egc-304	38	30	weight	weight	NOUN
egc-304	38	31	loss	loss	NOUN
egc-304	38	32	and	and	CCONJ
egc-304	38	33	reduces	reduce	VERB
egc-304	38	34	insulin	insulin	NOUN
egc-304	38	35	resistance	resistance	NOUN
egc-304	38	36	;	;	PUNCT
egc-304	38	37	has	have	VERB
egc-304	38	38	a	a	DET
egc-304	38	39	positive	positive	ADJ
egc-304	38	40	effect	effect	NOUN
egc-304	38	41	on	on	ADP
egc-304	38	42	the	the	DET
egc-304	38	43	brain	brain	NOUN
egc-304	38	44	and	and	CCONJ
egc-304	38	45	nervous	nervous	ADJ
egc-304	38	46	system	system	NOUN
egc-304	38	47	;	;	PUNCT
egc-304	38	48	helps	help	VERB
egc-304	38	49	prevent	prevent	VERB
egc-304	38	50	hypertension	hypertension	NOUN
egc-304	38	51	.	.	PUNCT
egc-304	39	1	references	reference	NOUN
egc-304	39	2	1	1	NUM
egc-304	39	3	.	.	PUNCT
egc-304	40	1	karonova	karonova	PROPN
egc-304	40	2	t.l	t.l	PROPN
egc-304	40	3	.	.	PROPN
egc-304	40	4	,	,	PUNCT
egc-304	40	5	belyaeva	belyaeva	PROPN
egc-304	40	6	o.d	o.d	PROPN
egc-304	40	7	.	.	PROPN
egc-304	40	8	,	,	PUNCT
egc-304	40	9	bystrova	bystrova	PROPN
egc-304	40	10	a.a	a.a	PROPN
egc-304	40	11	.	.	PROPN
egc-304	40	12	,	,	PUNCT
egc-304	40	13	andreeva	andreeva	PROPN
egc-304	40	14	a.t	a.t	PROPN
egc-304	40	15	.	.	PROPN
egc-304	40	16	,	,	PUNCT
egc-304	40	17	kozyreva	kozyreva	PROPN
egc-304	40	18	a.a	a.a	PROPN
egc-304	40	19	.	.	PROPN
egc-304	40	20	,	,	PUNCT
egc-304	40	21	tsvetkova	tsvetkova	PROPN
egc-304	40	22	e.v	e.v	PROPN
egc-304	40	23	.	.	PROPN
egc-304	40	24	,	,	PUNCT
egc-304	40	25	burmistrova	burmistrova	PROPN
egc-304	40	26	d.a	d.a	PROPN
egc-304	40	27	.	.	PROPN
egc-304	40	28	,	,	PUNCT
egc-304	40	29	kostareva	kostareva	PROPN
egc-304	40	30	a.a	a.a	PROPN
egc-304	40	31	.	.	PROPN
egc-304	40	32	,	,	PUNCT
egc-304	40	33	shlyakhto	shlyakhto	PROPN
egc-304	40	34	e.v	e.v	PROPN
egc-304	40	35	.	.	PROPN
egc-304	40	36	bsmi	bsmi	PROPN
egc-304	40	37	,	,	PUNCT
egc-304	40	38	apai	apai	NOUN
egc-304	40	39	,	,	PUNCT
egc-304	40	40	taqi	taqi	NOUN
egc-304	40	41	,	,	PUNCT
egc-304	40	42	and	and	CCONJ
egc-304	40	43	foki	foki	ADJ
egc-304	40	44	polymorphisms	polymorphism	NOUN
egc-304	40	45	of	of	ADP
egc-304	40	46	the	the	DET
egc-304	40	47	vitamin	vitamin	NOUN
egc-304	40	48	d	d	NOUN
egc-304	40	49	receptor	receptor	NOUN
egc-304	40	50	gene	gene	NOUN
egc-304	40	51	and	and	CCONJ
egc-304	40	52	blood	blood	NOUN
egc-304	40	53	lipid	lipid	NOUN
egc-304	40	54	spectrum	spectrum	NOUN
egc-304	40	55	parameters	parameter	NOUN
egc-304	40	56	in	in	ADP
egc-304	40	57	women	woman	NOUN
egc-304	40	58	of	of	ADP
egc-304	40	59	late	late	ADJ
egc-304	40	60	reproductive	reproductive	ADJ
egc-304	40	61	age	age	NOUN
egc-304	40	62	.	.	PUNCT
egc-304	41	1	arterial	arterial	ADJ
egc-304	41	2	hypertension	hypertension	NOUN
egc-304	41	3	.	.	PUNCT
egc-304	42	1	2019	2019	NUM
egc-304	42	2	.	.	X
egc-304	43	1	2	2	X
egc-304	43	2	.	.	X
egc-304	43	3	povalyaeva	povalyaeva	PROPN
egc-304	43	4	a.a	a.a	PROPN
egc-304	43	5	.	.	PROPN
egc-304	43	6	,	,	PUNCT
egc-304	43	7	pigarova	pigarova	PROPN
egc-304	43	8	e.a	e.a	PROPN
egc-304	43	9	.	.	PROPN
egc-304	43	10	,	,	PUNCT
egc-304	43	11	dzeranova	dzeranova	PROPN
egc-304	43	12	l.k	l.k	PROPN
egc-304	43	13	.	.	PROPN
egc-304	43	14	,	,	PUNCT
egc-304	43	15	rozhinskaya	rozhinskaya	PROPN
egc-304	43	16	l.ya	l.ya	PROPN
egc-304	43	17	.	.	PROPN
egc-304	43	18	relationship	relationship	NOUN
egc-304	43	19	between	between	ADP
egc-304	43	20	vitamin	vitamin	NOUN
egc-304	43	21	d	d	NOUN
egc-304	43	22	status	status	NOUN
egc-304	43	23	and	and	CCONJ
egc-304	43	24	the	the	DET
egc-304	43	25	development	development	NOUN
egc-304	43	26	and	and	CCONJ
egc-304	43	27	course	course	NOUN
egc-304	43	28	of	of	ADP
egc-304	43	29	type	type	NOUN
egc-304	43	30	1	1	NUM
egc-304	43	31	diabetes	diabetes	NOUN
egc-304	43	32	mellitus	mellitus	NOUN
egc-304	43	33	.	.	PUNCT
egc-304	44	1	obesity	obesity	NOUN
egc-304	44	2	and	and	CCONJ
egc-304	44	3	metabolism	metabolism	NOUN
egc-304	44	4	.	.	PUNCT
egc-304	45	1	2020;17(1):82	2020;17(1):82	NUM
egc-304	45	2	-	-	SYM
egc-304	45	3	87	87	NUM
egc-304	45	4	.	.	PUNCT
egc-304	46	1	3	3	X
egc-304	46	2	.	.	X
egc-304	46	3	zittermann	zittermann	PROPN
egc-304	46	4	a.	a.	PROPN
egc-304	46	5	,	,	PUNCT
egc-304	46	6	filatova	filatova	PROPN
egc-304	47	1	t.e	t.e	PROPN
egc-304	47	2	.	.	PROPN
egc-304	47	3	et	et	PROPN
egc-304	47	4	al	al	PROPN
egc-304	47	5	.	.	PROPN
egc-304	47	6	,	,	PUNCT
egc-304	47	7	2019	2019	NUM
egc-304	47	8	;	;	PUNCT
egc-304	47	9	yankovskaya	yankovskaya	PROPN
egc-304	47	10	l.v	l.v	PROPN
egc-304	47	11	.	.	PROPN
egc-304	47	12	et	et	PROPN
egc-304	47	13	al	al	PROPN
egc-304	47	14	.	.	PROPN
egc-304	47	15	,	,	PUNCT
egc-304	47	16	2019	2019	NUM
egc-304	47	17	;	;	PUNCT
egc-304	47	18	imga	imga	PROPN
egc-304	47	19	n.n	n.n	PROPN
egc-304	47	20	.	.	PROPN
egc-304	47	21	et	et	PROPN
egc-304	47	22	al	al	PROPN
egc-304	47	23	.	.	PROPN
egc-304	47	24	,	,	PUNCT
egc-304	47	25	2019	2019	NUM
egc-304	47	26	.	.	PUNCT
egc-304	48	1	4	4	X
egc-304	48	2	.	.	X
egc-304	48	3	agrawal	agrawal	PROPN
egc-304	48	4	a.	a.	PROPN
egc-304	48	5	,	,	PUNCT
egc-304	48	6	mahey	mahey	PROPN
egc-304	48	7	r.	r.	PROPN
egc-304	48	8	,	,	PUNCT
egc-304	48	9	kachhawa	kachhawa	PROPN
egc-304	49	1	g.	g.	PROPN
egc-304	49	2	et	et	PROPN
egc-304	50	1	al	al	PROPN
egc-304	50	2	.	.	PROPN
egc-304	50	3	comparison	comparison	NOUN
egc-304	50	4	of	of	ADP
egc-304	50	5	metformin	metformin	NOUN
egc-304	50	6	plus	plus	CCONJ
egc-304	50	7	myoinositol	myoinositol	NOUN
egc-304	50	8	vs	vs	ADP
egc-304	50	9	metformin	metformin	NOUN
egc-304	50	10	alone	alone	ADV
egc-304	50	11	in	in	ADP
egc-304	50	12	pcos	pcos	NOUN
egc-304	50	13	women	woman	NOUN
egc-304	50	14	undergoing	undergo	VERB
egc-304	50	15	ovulation	ovulation	NOUN
egc-304	50	16	induction	induction	NOUN
egc-304	50	17	cycles	cycle	NOUN
egc-304	50	18	:	:	PUNCT
egc-304	50	19	randomized	randomize	VERB
egc-304	50	20	controlled	control	VERB
egc-304	50	21	trial	trial	NOUN
egc-304	50	22	.	.	PUNCT
egc-304	51	1	gynecol	gynecol	ADJ
egc-304	51	2	endocrinol	endocrinol	NOUN
egc-304	51	3	.	.	PUNCT
egc-304	52	1	2023;35(6):511–514	2023;35(6):511–514	NUM
egc-304	52	2	.	.	X
egc-304	53	1	doi	doi	NOUN
egc-304	53	2	:	:	PUNCT
egc-304	53	3	10.1080/09513590.2018.1549656	10.1080/09513590.2018.1549656	NUM
egc-304	53	4	.	.	X
egc-304	54	1	5	5	X
egc-304	54	2	.	.	X
egc-304	54	3	khasanova	khasanova	PROPN
egc-304	54	4	g.kh	g.kh	PROPN
egc-304	54	5	.	.	PUNCT
egc-304	54	6	best	good	ADJ
egc-304	54	7	practices	practice	NOUN
egc-304	54	8	in	in	ADP
egc-304	54	9	the	the	DET
egc-304	54	10	dietotherapeutics	dietotherapeutic	NOUN
egc-304	54	11	of	of	ADP
egc-304	54	12	hypertension	hypertension	NOUN
egc-304	54	13	.	.	PUNCT
egc-304	55	1	scientific	scientific	ADJ
egc-304	55	2	electronic	electronic	ADJ
egc-304	55	3	journal	journal	NOUN
egc-304	55	4	"	"	PUNCT
egc-304	55	5	academic	academic	ADJ
egc-304	55	6	journalism	journalism	NOUN
egc-304	55	7	"	"	PUNCT
egc-304	55	8	,	,	PUNCT
egc-304	55	9	no	no	INTJ
egc-304	55	10	.	.	NOUN
egc-304	55	11	12	12	NUM
egc-304	55	12	-	-	NOUN
egc-304	55	13	2/2022	2/2022	NUM
egc-304	55	14	/	/	SYM
egc-304	55	15	https://aeterna	https://aeterna	NOUN
egc-304	55	16	-	-	PUNCT
egc-304	55	17	ufa.ruhttps://aeterna	ufa.ruhttps://aeterna	NOUN
egc-304	55	18	-	-	PUNCT
egc-304	55	19	ufa.ru	ufa.ru	NOUN
egc-304	55	20	/	/	SYM
egc-304	55	21	events	event	NOUN
egc-304	55	22	/	/	SYM
egc-304	55	23	ap	ap	PROPN
egc-304	55	24	.	.	PROPN
egc-304	56	1	6	6	NUM
egc-304	56	2	.	.	X
egc-304	56	3	khasanova	khasanova	PROPN
egc-304	56	4	g.kh	g.kh	PROPN
egc-304	56	5	.	.	PROPN
egc-304	56	6	effect	effect	NOUN
egc-304	56	7	of	of	ADP
egc-304	56	8	diet	diet	NOUN
egc-304	56	9	therapy	therapy	NOUN
egc-304	56	10	and	and	CCONJ
egc-304	56	11	nutriceutic	nutriceutic	ADJ
egc-304	56	12	support	support	NOUN
egc-304	56	13	in	in	ADP
egc-304	56	14	metabolic	metabolic	NOUN
egc-304	56	15	syndrome	syndrome	NOUN
egc-304	56	16	in	in	ADP
egc-304	56	17	women	woman	NOUN
egc-304	56	18	of	of	ADP
egc-304	56	19	fertile	fertile	ADJ
egc-304	56	20	age	age	NOUN
egc-304	56	21	.	.	PUNCT
egc-304	57	1	galaxy	galaxy	PROPN
egc-304	57	2	international	international	ADJ
egc-304	57	3	interdisciplinary	interdisciplinary	ADJ
egc-304	57	4	research	research	NOUN
egc-304	57	5	journal	journal	NOUN
egc-304	57	6	(	(	PUNCT
egc-304	57	7	giirj	giirj	NOUN
egc-304	57	8	)	)	PUNCT
egc-304	57	9	.	.	PUNCT
egc-304	58	1	vol	vol	NOUN
egc-304	58	2	.	.	PROPN
egc-304	58	3	11	11	NUM
egc-304	58	4	,	,	PUNCT
egc-304	58	5	issue	issue	NOUN
egc-304	58	6	2	2	NUM
egc-304	58	7	,	,	PUNCT
egc-304	58	8	feb	feb	PROPN
egc-304	58	9	.	.	PROPN
egc-304	58	10	(	(	PUNCT
egc-304	58	11	2023	2023	NUM
egc-304	58	12	)	)	PUNCT
egc-304	58	13	.	.	PUNCT
egc-304	59	1	https://giirj.com/index.php/giirj/article/view/4763	https://giirj.com/index.php/giirj/article/view/4763	PROPN
egc-304	59	2	.	.	PUNCT
egc-304	60	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	60	2	eglobal	eglobal	PROPN
egc-304	60	3	congress	congress	PROPN
egc-304	60	4	hosted	host	VERB
egc-304	60	5	online	online	ADV
egc-304	60	6	from	from	ADP
egc-304	60	7	dubai	dubai	PROPN
egc-304	60	8	,	,	PUNCT
egc-304	60	9	u.	u.	PROPN
egc-304	60	10	a.	a.	PROPN
egc-304	60	11	e.	e.	PROPN
egc-304	60	12	,	,	PUNCT
egc-304	60	13	e	e	PROPN
egc-304	60	14	conference	conference	NOUN
egc-304	60	15	.	.	PUNCT
egc-304	61	1	date	date	NOUN
egc-304	61	2	:	:	PUNCT
egc-304	61	3	30th	30th	ADJ
egc-304	61	4	january	january	PROPN
egc-304	61	5	2025	2025	NUM
egc-304	61	6	website	website	NOUN
egc-304	61	7	:	:	PUNCT
egc-304	61	8	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN
egc-304	61	9	issn	issn	PROPN
egc-304	61	10	(	(	PUNCT
egc-304	61	11	e	e	NOUN
egc-304	61	12	):	):	PUNCT
egc-304	61	13	2836	2836	NUM
egc-304	61	14	-	-	SYM
egc-304	61	15	3612	3612	NUM
egc-304	61	16	48	48	NUM
egc-304	61	17	|	|	ADV
egc-304	61	18	p	p	NOUN
egc-304	61	19	a	a	DET
egc-304	61	20	g	g	NOUN
egc-304	61	21	e	e	NOUN
egc-304	61	22	7	7	NUM
egc-304	61	23	.	.	PUNCT
egc-304	62	1	khasanova	khasanova	PROPN
egc-304	62	2	g.kh	g.kh	PROPN
egc-304	62	3	.	.	PROPN
egc-304	62	4	,	,	PUNCT
egc-304	62	5	tukhtaeva	tukhtaeva	PROPN
egc-304	62	6	n.kh	n.kh	PROPN
egc-304	62	7	.	.	PUNCT
egc-304	62	8	metabolic	metabolic	PROPN
egc-304	62	9	syndrome	syndrome	NOUN
egc-304	62	10	in	in	ADP
egc-304	62	11	women	woman	NOUN
egc-304	62	12	of	of	ADP
egc-304	62	13	fertile	fertile	ADJ
egc-304	62	14	age	age	NOUN
egc-304	62	15	:	:	PUNCT
egc-304	62	16	diet	diet	NOUN
egc-304	62	17	therapy	therapy	NOUN
egc-304	62	18	and	and	CCONJ
egc-304	62	19	nutraceutical	nutraceutical	ADJ
egc-304	62	20	support	support	NOUN
egc-304	62	21	.	.	PUNCT
egc-304	63	1	tibbiyot	tibbiyot	PROPN
egc-304	63	2	va	va	PROPN
egc-304	63	3	sport	sport	NOUN
egc-304	63	4	.	.	PUNCT
egc-304	64	1	scientific	scientific	ADJ
egc-304	64	2	and	and	CCONJ
egc-304	64	3	practical	practical	ADJ
egc-304	64	4	journal	journal	NOUN
egc-304	64	5	.	.	PUNCT
egc-304	65	1	no	no	INTJ
egc-304	65	2	.	.	NOUN
egc-304	65	3	2	2	NUM
egc-304	65	4	,	,	PUNCT
egc-304	65	5	2023	2023	NUM
egc-304	65	6	.	.	PUNCT
egc-304	66	1	8	8	NUM
egc-304	66	2	.	.	X
egc-304	66	3	khasanova	khasanova	PROPN
egc-304	66	4	g.kh	g.kh	PROPN
egc-304	66	5	.	.	PROPN
egc-304	66	6	,	,	PUNCT
egc-304	66	7	tuxtaeva	tuxtaeva	PROPN
egc-304	66	8	n.x	n.x	PROPN
egc-304	66	9	.	.	PROPN
egc-304	66	10	metabolic	metabolic	PROPN
egc-304	66	11	syndrome	syndrome	NOUN
egc-304	66	12	and	and	CCONJ
egc-304	66	13	d	d	ADP
egc-304	66	14	vitamin	vitamin	NOUN
egc-304	66	15	metabolism	metabolism	NOUN
egc-304	66	16	:	:	PUNCT
egc-304	66	17	clinical	clinical	ADJ
egc-304	66	18	and	and	CCONJ
egc-304	66	19	laboratory	laboratory	NOUN
egc-304	66	20	correction	correction	NOUN
egc-304	66	21	.	.	PUNCT
egc-304	67	1	uzbekistan	uzbekistan	PROPN
egc-304	67	2	cardiology	cardiology	NOUN
egc-304	67	3	.	.	PUNCT
egc-304	68	1	international	international	ADJ
egc-304	68	2	journal	journal	PROPN
egc-304	68	3	of	of	ADP
egc-304	68	4	cardiology	cardiology	NOUN
egc-304	68	5	.	.	PUNCT
egc-304	69	1	no	no	INTJ
egc-304	69	2	.	.	NOUN
egc-304	69	3	3	3	NUM
egc-304	69	4	/	/	SYM
egc-304	69	5	2023	2023	NUM
egc-304	69	6	(	(	PUNCT
egc-304	69	7	69	69	NUM
egc-304	69	8	)	)	PUNCT
egc-304	69	9	.	.	PUNCT
egc-304	70	1	(	(	PUNCT
egc-304	70	2	abstracts	abstract	NOUN
egc-304	70	3	of	of	ADP
egc-304	70	4	the	the	DET
egc-304	70	5	international	international	ADJ
egc-304	70	6	scientific	scientific	ADJ
egc-304	70	7	and	and	CCONJ
egc-304	70	8	practical	practical	ADJ
egc-304	70	9	conference	conference	NOUN
egc-304	70	10	"	"	PUNCT
egc-304	70	11	preventive	preventive	ADJ
egc-304	70	12	cardiology	cardiology	NOUN
egc-304	70	13	:	:	PUNCT
egc-304	70	14	from	from	ADP
egc-304	70	15	primary	primary	ADJ
egc-304	70	16	prevention	prevention	NOUN
egc-304	70	17	to	to	ADP
egc-304	70	18	cardiac	cardiac	ADJ
egc-304	70	19	rehabilitation	rehabilitation	NOUN
egc-304	70	20	"	"	PUNCT
egc-304	70	21	competition	competition	NOUN
egc-304	70	22	of	of	ADP
egc-304	70	23	young	young	ADJ
egc-304	70	24	scientists	scientist	NOUN
egc-304	70	25	)	)	PUNCT
egc-304	70	26	.	.	PUNCT
egc-304	71	1	p.	p.	NOUN
egc-304	71	2	122	122	NUM
egc-304	71	3	.	.	PUNCT
egc-304	72	1	https://eglobalcongress.com/index.php/egc	https://eglobalcongress.com/index.php/egc	PROPN